About Cytoswim
Cytoswim is a company based in Coventry (United Kingdom) founded in 2019. Cytoswim has raised $129.35 thousand across 2 funding rounds from investors including Oxford Technology and UK Research and Innovation. The company has 4 employees as of February 28, 2022. Cytoswim offers products and services including SpermAlign. Cytoswim operates in a competitive market with competitors including Memphasys, Reproductive Solutions and ZyMot, among others.
- Headquarter Coventry, United Kingdom
- Employees 4 as on 28 Feb, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cytoswim Ltd
- Date of Incorporation 21 Feb, 2019
- Jurisdiction COVENTRY, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$129.35 K (USD)
in 2 rounds
-
Latest Funding Round
$394.7 K (USD), Grant
Jun 01, 2019
-
Investors
Oxford Technology
& 1 more
-
Employee Count
4
as on Feb 28, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cytoswim
Cytoswim offers a comprehensive portfolio of products and services, including SpermAlign.
Tool for enhancing sperm quality in assisted reproductive technology procedures.
Funding Insights of Cytoswim
Cytoswim has successfully raised a total of $129.35K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $394.7 thousand completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cytoswim
Cytoswim has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Oxford Technology and UK Research and Innovation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage micro-VC investments are focused on UK companies.
|
Locked | Locked | Locked | |
|
Research and innovation funding is managed for UK advancement.
|
Locked | Locked | Locked |
Investor details for Cytoswim
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cytoswim
Investment portfolio details for Cytoswim
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cytoswim
Detailed financials for Cytoswim
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cytoswim Comparisons
Peer comparison for Cytoswim
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cytoswim
Cytoswim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Memphasys, Reproductive Solutions and ZyMot, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reproductive cell separation techniques for assisted reproduction are developed.
|
|
| Locked | Locked | Locked |
Developer of advanced sperm collection and processing technologies. It offers solutions for at-home semen analysis and in-clinic sperm processing, improving sperm quality and increasing the chances of successful conception. The company's products are designed to enhance sperm viability during collection, transport, and preparation for various fertility treatments, including IUI, IVF, and ICSI. These technologies aim to simplify the process for both patients and healthcare providers, improving outcomes and reducing stress. The company also provides support and resources for patients and clinics.
|
|
| Locked | Locked | Locked |
Develops innovative sperm separation devices for medical applications.
|
Detailed competitors of Cytoswim
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cytoswim
Complete news archive for Cytoswim
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytoswim
Cytoswim was founded in 2019.
Cytoswim is headquartered in Coventry, United Kingdom.
Max Meissner is the current CEO of Cytoswim.
Cytoswim is a funded company, having raised a total of $129.35K across 2 funding rounds to date.
As of Feb 28, 2022, the latest employee count at Cytoswim is 4.
Cytoswim was founded in 2019 and is based in Coventry, United Kingdom. Tools for sperm selection in assisted reproduction are developed by the company, focusing on advancements in reproductive medicine. Operations center on biotechnology solutions to improve fertility treatments. The CEO position is held by Max Meissner. Services target healthcare providers in the assisted reproduction sector.
Cytoswim's top competitors include Memphasys, Reproductive Solutions and ZyMot.
Cytoswim offers SpermAlign.
Cytoswim has 2 investors. Key investors include Oxford Technology, and UK Research and Innovation.